MAP microba life sciences limited

News: MAP Microba Life Sciences To Acquire Invivo Clinical

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Oct 19 (Reuters) - Microba Life Sciences Ltd (MAP) :

    • MICROBA TO ACQUIRE UK MICROBIOME LEADER INVIVO CLINICAL
    • ACQUISITION EXPANDS MICROBA'S SCALE AND INTERNATIONAL PRESENCE WITH FY23 REVENUES OF A$14.3M ON A PRO-FORMA BASIS
    • WILL BE ACQUIRED FOR A PURCHASE PRICE OF APPROXIMATELY A$12.5 MILLION, PLUS UP TO A$8.7 MILLION IN EARN-OUT CONSIDERATION
    • SIGNED A SHARE PURCHASE AGREEMENT FOR ACQUISITION OF 100% OF INVIVO CLINICAL LIMITED
    • EXPECTED ABOUT 87 MILLION SHARES WILL BE ISSUED UNDER ENTITLEMENT OFFER
    • POST ENTITLEMENT OFFER, MICROBA’S PRO FORMA NET CASH AT 30 SEPT EXPECTED TO BE A$28.3 MILLION
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.2¢
Change
-0.004(4.17%)
Mkt cap ! $47.38M
Open High Low Value Volume
9.6¢ 9.6¢ 9.2¢ $11.09K 118.8K

Buyers (Bids)

No. Vol. Price($)
5 20774 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 114482 1
View Market Depth
Last trade - 15.11pm 29/07/2025 (20 minute delay) ?
MAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.